Journal of Pharmaceutical Health Services Research

Cover image for Vol. 5 Issue 4

Edited By: Albert Wertheimer, Temple University Pharmacy School, USA

Online ISSN: 1759-8893



Author Guidelines


Online Only from 2015

Effective with the volume, JPHSR will be published in an online-only format. Your accepted article will be published in 2015 and will therefore appear in the online edition. No printed edition will be published. All normal author benefits and services remain in place e.g. authors will continue to be able to order print reprints of articles if required. Furthermore, there will be no cost to authors for the publication of colour images in the online-only edition.

Contacts for author queries:

Editorial Office (for submission queries and papers under review): JPHSReditorialoffice@wiley.com

Production Editor (for accepted and published papers): jphs@wiley.com

Editorial Policy
Journal of Pharmaceutical Health Services Research considers all manuscripts on the strict condition that they have not been published already, nor are they under consideration for publication or in press elsewhere.

Journal of Pharmaceutical Health Services Research publishes manuscripts on all aspects of research within the field of health services research that relate to pharmaceuticals. The journal publishes original research papers, critical reviews and short communications.

Contributions to Journal of Pharmaceutical Health Services Research will be subjected to review at the discretion of the Editorial Office and papers accepted may be subject to editorial revision. Decisions regarding acceptability will be made on the basis of the quality of science, the contribution of the work to the field, the suitability of the work for the Journal and the presentation of the manuscript. Contributions submitted by the Journal's Editors and Editorial Board members are subject to the same peer review standards as papers submitted by all other authors. We aim to present authors with an initial decision regarding the acceptability of submitted papers within ten weeks of receipt of the manuscript. Further information can be found below.

Manuscript Preparation  

General guidelines

  • All contributing authors of a manuscript should include their full name, affiliation, postal address, telephone and fax numbers and email address on the cover page of the manuscript. One author should be identified as the corresponding author.
  • For all manuscripts non-discriminatory (inclusive) language should be used.
  • Authors are urged to be succinct, to use the minimum number of tables and figures necessary and to avoid repetition of information between these two media. Given the competition for space within the journal, the length of submission in relation to its likely contribution will be taken into account with regard to acceptability. Guidelines on length are provided below.
  • The pages and lines of the manuscript must be numbered.

Ethical guidelines

  • Authors should supply a conflict of interest statement with their submitted manuscript, detailing any financial or personal relationships that may bias their work, or a declaration that they have no conflicts of interest to disclose.
  • Original research studies involving animals or human volunteers must include details of ethical approval. Papers that do not comply with internationally accepted ethical criteria will not be accepted for publication.
  • Identifying details of patients and study participants should be omitted. If identifying information is essential for scientific purposes, or if there is any doubt about the adequacy of the anonymity protection used, the patient (or parent/guardian) must give written informed consent for publication. Authors should provide this statement of informed consent upon submission of the manuscript.
  • Manuscripts reporting randomised controlled trials should include a checklist and flowchart in accordance with the CONSORT Statement guidelines. The checklist should be submitted as a supplementary file, and the flowchart as a figure.
  • Systematic reviews must be submitted together with a checklist and flowchart in accordance with the PRISMA guidelines. The checklist should be submitted as a supplementary file, and the flowchart as a figure.  

Click here for our detailed guidelines.

Language

Manuscripts are accepted only in English. Authors whose first language is not English are recommended to ask a native speaker to proofread their manuscript before submission. There are also a number of services that provide mentoring, advice and copyediting to support authors unfamiliar with writing academic research papers for publication in international journals. Authors are encouraged to make use of services such as AuthorAID if necessary.  

Critical reviews
Systematic review articles critically assessing published material on any aspect of pharmaceutical health services research will be considered. In particular authors should describe their literature search method and results, state the quality criteria used to assess papers and explain reasons for excluded studies. Review articles should normally be a maximum of 6000 words. Authors may contact the Editorial Office before submitting a review article if they wish to discuss their manuscript.

Short communications
Short communications will be considered for small pieces of research (e.g. pilot studies, preliminary results) not meeting the criteria for a full paper, or personal opinions on a particular topic. Short research papers should follow the same structure as a full paper but should have proportionately shorter Introduction and Discussion sections. They should be a maximum of 1000 words, with a maximum of two tables and figures, and ten references.

Case Reports
The journal does not accept case reports for publication. Authors of case reports are encouraged to submit to the Wiley Open Access journal, Clinical Case Reports www.clinicalcasesjournal.com which aims to directly improve health outcomes by identifying and disseminating examples of best clinical practice.

Original research papers  
Original research papers should not exceed 4000 words, although exceptions may be made in special circumstances.

Abstract

  • Structured abstracts are required for all papers and should include objectives, methods, key findings and conclusions.
  • Approximate length: 250 words

Keywords

  • Three to six keywords should be supplied for all papers.

Introduction

  • An introduction should provide a background to the study (appropriate for an international audience) and should clearly state the specific aims of the study. Please ensure that any abbreviations and all symbols used in equations are fully defined.
  • Approximate length: 500-1000 words

Methods

  • This section should describe the subjects, setting and methods in sufficient detail to allow the study to be replicated. Please include details of ethical approval in this section.
  • Approximate length: 500-1000 words

Results

  • This section should provide detailed response rates. It is essential to include statistical analyses or other indicators to enable assessment of the variance of replicates of the experiments. Data should not be repeated in figures and tables.
  • Approximate length: 1000-1500 words

Discussion

  • The discussion section should summarise the main findings of the study, followed by a critique of the strengths and limitations of the research. The results should then be discussed in the context of international published literature and the contribution made to the field. Any policy limitations should be included.
  • Approximate length: 1000 words

Conclusions

  • A brief conclusions section should summarise the salient findings of the study. Authors are strongly advised to emphasise the contribution made to the field by their study in this section.
  • Approximate length: 200 words


Tables

  • Please keep the number of tables to a minimum.
  • Tables should be numbered consecutively (Table 1, Table 2 etc) and each table must start on a separate page at the end of the manuscript.
  • Each table must have a title. Each table legend, in paragraph form, should briefly describe the content and define any abbreviations used. If values are cited in a table, the unit of measurement must be stated.
  • Tables should not be ruled.

Figures

  • Please keep the number of figures to a minimum.
  • Each figure must have a title. Each figure legend, in paragraph form, should briefly describe the content and define any abbreviations used. If values are cited in a figure, the unit of measurement must be stated. Graphs must have clearly labelled axes. A key may be included if appropriate.
  • It is in the author's interest to provide the highest quality figure format possible. Please be sure that all imported scanned material is scanned at the appropriate resolution: 1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour.
  • Files should be saved as one of the following formats: TIFF (tagged image file format), PostScript or EPS (encapsulated PostScript), and should contain all the necessary font information and the source file of the application (e.g. CorelDraw/Mac, CorelDraw/PC).
  • Figures must be saved separate to text. Please do not embed figures in the paper file. The manuscript should indicate the position of the figures (e.g. see Figure 1) and all figures should be numbered consecutively in the order in which they appear in the paper. In multi-part figures, each part should be labelled (e.g. Figure 1(a), Figure 1(b)). The filename for a graphic should be descriptive of the graphic, e.g. Figure1, Figure2a.
  • There are a limited number of colour pages within the journal’s annual page allowance. Authors should restrict their use of colour to situations where it is necessary on scientific, and not merely cosmetic, grounds. Authors of accepted papers who propose publishing figures in colour in the print version should consult the Production Editor at proof stage to agree on an appropriate number of colour pages. The decision of the Publisher is final.

Acknowledgements and Funding

  • Funding acknowledgements should be written in the following form: “This work was supported by the Medical Research Council [grant number xxx]”
  • If the research has not been funded by any specific project grant, please include the statement: “This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors”

References

  • References in the text are cited sequentially by number. All citations in the text must appear in the reference list and vice versa. The only exceptions to this are manuscripts not yet in press or published online, papers reported at meetings, or personal communications – these should be cited only in the text, not as a formal reference. Authors should get permission from the source to cite personal communications or unpublished work.
  • At the end of the manuscript, references should be listed in numerical order as they appear in the text. Serial titles should be abbreviated in accordance with the standard approved abbreviations used by PubMed or BIOSIS. One-word titles are never abbreviated. Article identifiers, such as the Digital Object Identifier (DOI) or PubMed Unique Identifier (PMID), may be included as appropriate. State the references according to the format of the following examples:  

Journal references  

Authors are required to archive any web references before citing them using WebCite ® technology (http://www.webcitation.org). This is an entirely free service that ensures that cited web material will remain available to readers in the future.

One author:
Szeto HH. Simultaneous determination of meperidine and normeperidine in biofluids. J Chromatogr 1976; 125: 503–510.  

Two authors:
Vu-Duc T, Vernay A. Simultaneous detection and quantitation of O6-monoacetylmorphine, morphine and codeine in urine by gas chromatography with nitrogen specific and/or flame ionization detection. Biomed Chromatogr 1990; 4(2): 65–69.  

Three or more authors: Huestis MA et al. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing. J Anal Toxicol 2000; 4(Suppl.3): 509–521.    

Article in press:
Ladines CA et al. Impaired renal D1-like and D2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 2008 (in press).  

Electronic publication ahead of print:
Teeuwen PHE. Doppler-guided intra-operative fluid management during major abdominal surgery: a systematic review and meta-analysis. Int J Clin Pract (accessed 21 November 2007, epub ahead of print).  

Online serial:
Margolis PA et al. From concept to application: the impact of a community-wide intervention to improve the delivery of preventive services to children. Pediatrics [online] 2001; 108:e42. www.pediatrics.org/cgi/content/full/108/3/e42 (accessed 20 September 2001).  

Corporate author:
The Cardiac Society of Australia and New Zealand . Clinical exercise stress testing. Safety and performance guidelines. Med J Aust 1996; 164: 282–284.  

Anonymous author:
Anon. Coffee drinking and cancer of the pancreas. BMJ 1981; 283: 628.  

Author with prefix and/or suffix in their name:
Humphreys Jnr, Sir Robert and Adams T.

Reference style in the modern age. J Bib Cit 2008; 1: 1–10.  

Article not in English:
Sokolov S et al. [Studies of neurotropic activity of new compounds isolated from Rhodiola rosea L.] Khim Farm Zh 1985; 19: 1367–1371 [in Russian].  

Book references  

Book by a single author or group of authors working together as a single author:
Cole MD, Caddy B. The Analysis of Drugs of Abuse: An instruction manual, 2nd edn. New York : Ellis Horwood, 1995.  

An edited book:
Hoepfner E et al. eds. Fiedler Encyclopedia of Excipients for Pharmaceuticals, Cosmetics and Related Areas, 5th edn. Aulendorf: Editio Cantor Verlag, 2002.  

An article in an edited book:
Sanders PA. Aerosol packaging of pharmaceuticals. In: Banker GS, Rhodes CT , eds. Modern Pharmaceutics. New York : Marcel Dekker, 1979: 591–626.  

A book in a series:
Scott RPW. Chromatographic Detectors – Design, Function, and Operation. Chromatographic Science Series, 73, Cazes J, ed. New York : Mercel Dekker, 1966.  

Other references  

Article in conference proceedings:
Dumasia MC et al. LC/MS analysis of intact steroid conjugates: a preliminary study on the quantification of testosterone sulphate in equine urine. In: Auer DE, Houghton E, eds. Proceedings of the 11th International Conference of Racing Analysts and Veterinarians. Newmarket : R & W Publications ( Newmarket ), 1966: 188–194.  

Standard:
ISO 9002. Quality Systems – Model for Quality Assurance in Production, Installation and Servicing Quality Management System. Geneva : ISO, 1994.  

Offline database or publication:
Dictionary of Natural Products. CD-ROM. London : Chapman & Hall/CRC, 2003.   Milazzo S et al. Laetrile treatment for cancer. Cochrane Database of Systematic Reviews, issue 2. London : Macmillan, 2006.  

Dissertation:
Youssef NM . School adjustment of children with congenital heart disease. Pittsburgh , Pennsylvania : University of Pittsburgh , 1988 (dissertation).

Manuscript Submission
All submissions should be made online at the Journal of Pharmaceutical Health Services Research Manuscripts site at http://mc.manuscriptcentral.com/jphsr Log-in or click the “Create Account” option if you are a first-time user.

If you are creating a new account:
1. After clicking on “Create Account”, enter your name and e-mail information and click “Next”. Your e-mail information is very important.
2. Enter your institution and address information as appropriate, and then click “Next.”
3. Enter a user ID and password of your choice (we recommend using your e-mail address as your user ID), and then select your area of expertise.
4. Click “Finish”. If you have an account, but have forgotten your log-in details, go to Password Help on the journal’s online submission system and enter your e-mail address. The system will send you an automatic user ID and a new temporary password.

Copyright

If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper. The corresponding author MUST submit the CTA as it is a requirement for publication.

For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:

CTA Terms and Conditions http://authorservices.wiley.com/bauthor/faqs_copyright.asp

For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):

Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html..

If you select the OnlineOpen option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.

Additionally. authors are themselves responsible for obtaining permission to reproduce copyright material from other sources.

Peer Review Process

Initial editorial screening
Submissions will be examined by the Editor to ensure that the manuscript falls within the priority remit of the journal. Those papers that do not fall within this remit will be returned to the author as rapidly as possible to facilitate resubmission to a more suitable publication.

Submission to reviewers
The manuscript will be sent to suitable individuals working in the field who have agreed to review the paper. Authors who have suggested reviewers at the time of submission may usually expect one of these individuals to be contacted, assuming that full contact details have been provided (including email address). At least two sets of reviewers’ comments will be utilized.

Initial editorial decision
The Editor will appraise the manuscript in the light of the recommendations made by the reviewers. One of the following decisions will be made:

  • accept as received  
  • accept subject to satisfactory completion of minor amendments  
  • reconsider after major revision (full revised manuscript and response to reviewers’ comments requested)
  • reject and recommend resubmission as short communication
  • reject

Papers are judged not only on the presence or absence of flaws to the work, but also on the likely contribution to the field. Those manuscripts that represent only a small incremental increase in the respective knowledge base will not be accepted irrespective of whether the work has been conducted in a sound manner.

Following receipt of the revised paper
The Editor reserves the right to make a decision on the paper without consulting the reviewers for a second time. Members of the Editorial Board may also be consulted at this stage. The final decision will be reported back to the author as quickly as possible. One of the following decisions will be made:

  • accept as received  
  • accept subject to satisfactory completion of requested revisions
  • reject

Authors may be required for make further minor amendments to their manuscript before it can be considered suitable for acceptance.

Accepted manuscripts sent to the Production Office
Accepted papers are forwarded to Wiley-Blackwell for processing. The paper may undergo copyediting for readability, consistency and formatting into the journal’s style prior to typesetting. PDF proofs will be sent by email to the Corresponding Author for checking; we ask that you return your corrected proofs as soon as possible. Failure to return the proof promptly will result in delays to the publication of the manuscript.

Authors may also be contacted at the copyediting and proofreading stages if queries arise during the production of their manuscript.

Reviewers are thanked and given the opportunity to view the final decision
Once a final decision has been made regarding a manuscript, reviewers have access to this decision and to view the other reviewers’ reports for that manuscript.

Proofreading guide
Authors should check their proofs for the following:

  • Typesetting or conversion errors
  • Figures and tables – position in the text, accurate reproduction and correct legend
  • Editing - language, house style, scientific nomenclature

There may be a list of queries attached to your proofs; if so, please make sure that all queries are answered and that the answers are returned with the marked proof.

Marking clear corrections:

  • To delete a character, word or block of text, cross out the material and write 'delete' in the margin.
  • If something has been marked for deletion and you decide to retain it, underscore the material in the text and write 'stet' in the margin.
  • If you wish to add some text, place a Y in the text and write the addition in the margin. If there is not enough room for the addition please attach a separate sheet and indicate clearly where it should be inserted in the text.
Supporting Information (online only)

Additional material such as video clips, lengthy Appendices (e.g. extensive reference lists or mathematical formulae/calculations), etc, that are relevant to a particular article but not suitable or essential for the print edition of the Journal, may also be considered for publication. Please refer to all supporting information in the manuscript using Table S1, Figure S1, etc, and supply such information as separate files (i.e. not embedded within the main manuscript). Further information on suitable file formats etc may be found here.

Online Open

OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee (currently $3000) to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://olabout.wiley.com/WileyCDA/Section/id-406241.html.

Any authors wishing to send their paper OnlineOpen will be required to complete the payment form available from our website at: https://authorservices.wiley.com/bauthor/onlineopen_order.asp . Prior to acceptance you should not inform the editorial office that you intend to publish your paper OnlineOpen. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit


Offprints

A PDF offprint of the online published article will be provided free of charge to the corresponding author, and may be distributed subject to the publisher's terms and conditions. Paper offprints of the printed published article may be purchased if ordered via the method stipulated on the instructions that will accompany the proofs.

Note to NIH Grantees

Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate  

SEARCH

SEARCH BY CITATION